Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

PRCT

PROCEPT BioRobotics Corp

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1588978Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$308.0M
Net Income FY2025
$(96.0M)
EPS (Basic, as reported)
$-1.72
Net Margin FY2025
-31.0%
ROE FY2025
-26.1%
Total Equity
$366.0M
Shares Out
57M
Business description

PROCEPT BioRobotics Corp — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 8 → 308 +107.5% CAGR
Fiscal yearFY2020⚑FY2021⚑FY2022FY2023FY2024FY2025
Revenue83475136224308
Cost of revenue(9)(19)(38)(65)(87)(112)
Gross profit(1)163771137196
Research & development(16)(19)(29)(48)(62)(71)
Selling, general & administrative(30)(51)(89)(132)(171)(229)
Total operating expenses(47)(70)(118)(180)(234)(300)
Operating income(48)(54)(81)(109)(97)(104)
Interest expense(5)(6)(5)(4)(4)(4)
Interest & investment income00281112
Other income (expense), net0000(1)0
Pre-tax income———(106)(91)(95)
Income tax expense000000
Net income(53)(60)(87)(106)(91)(96)
EPS — basic($14.47)($3.63)($1.96)($2.24)($1.75)($1.72)
EPS — diluted($14.47)($3.63)($1.96)($2.24)($1.75)($1.72)
Shares outstanding — basic (M)41644475256
Shares outstanding — diluted (M)41644475256
  • ⚑ Weighted-average shares changed ×4.00 between FY2020 and FY2021 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×2.75 between FY2021 and FY2022 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.